Globus Medical Inc (GMED)

$41.46 0.26 (0.63%)

17:41 EDT GMED Stock Quote Delayed 15 Minutes

Volume:

Previous Close $41.46

Market Cap 3.04B

PE Ratio 34.84

EPS 1.19

Volume (Avg. Vol.) 277,600

Day's Range 40.97 - 41.77

52-Week Range 38.01 - 57.83

Dividend & Yield N/A (N/A)

GMED Stock Predictions, Articles, and Globus Medical Inc News

From InvestorPlace
From the Web

7 Stocks to Buy That Lost 20% Over Past 90 Days

By Will Ashworth, InvestorPlace Contributor Jan 23, 2019

Thankfully, the start to 2019 has been much better than 2018's end. Here are seven stocks to buy that are due for a comeback this year.

5 AI Biotech Stocks to Bet On Now

By Harriet Lefton, Writer, TipRanks Jun 14, 2018

Marrying the benefits of modern medical science and advanced technology, these biotech stocks leverage AI to help keep people -- and portfolios -- healthier.

As Spinal Stocks Climb Toward Yearly Highs, There’s Still Room for Upside

By Chris Lau, InvestorPlace Contributor Jun 7, 2018

Companies in the medical appliances and equipment market of spines are sharply above yearly lows. Analyst coverage in the spinal stock sector is giving those stocks a temporary boost.

12 Health Care Equipment & Supplies Stocks to Sell Now

By Portfolio Grader Nov 21, 2016

This week, 12 Health Care Equipment & Supplies stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

21 Health Care Equipment & Supplies Stocks to Sell Now

By Portfolio Grader Nov 14, 2016

This week, the overall grades of 21 Health Care Equipment & Supplies stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

7 Debt-Free Stocks That Will Survive the Coming Bear Market

By Will Ashworth, InvestorPlace Contributor Sep 26, 2016

The fiscal responsibility of these seven stocks to buy will soon be rewarded when they eat well and Wall Street's grasshoppers starve.

Compare Brokers

Globus Medical Becomes Oversold (GMED)

From Market News Video May 22, 2019

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Abiomed (NASDAQ: ABMD), SAGE Therapeutics (NASDAQ: SAGE) and Globus Medical (NYSE: GMED)

From Analyst Ratings May 7, 2019

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Abiomed (ABMD – Research Report), SAGE Therapeutics (SAGE – Research Report) and Globus Medical (GMED – Research Report). Abiomed (ABMD) In a report issued on May 2, Sean Lavin from BTIG maintained a Buy rating on Abiomed, with

Best & Worst Performing Mid Cap Stocks for May 3, 2019

From StockNews.com May 3, 2019

<p><strong><a href="/stock/X/">X</a></strong> – X leads the way today as the best performing mid cap stock, closing up 17.30%.</p>

Globus Medical (GMED) Receives a Hold from Oppenheimer

From Analyst Ratings May 3, 2019

Oppenheimer analyst Steven Lichtman maintained a Hold rating on Globus Medical (GMED – Research Report) today and set a price target of $52. The company’s shares closed yesterday at $45.96. Lichtman commented: “Globus’ 1Q19 sales were $182.9M (+5.7% in constant currency), below our/ consensus $186.7M/ $186.6M estimates. Versus our estimates, U.S. core spine was about

The Daily Biotech Pulse: Obseva Reports Positive Endometriosis Drug Trial, Assembly Biosciences Execs Depart, Coherus Settles With Amgen

From Benzinga May 3, 2019

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 2) Alcon AG (NYSE: ALC) Dr....